InsidersTradesSigma
Follow the Hamlet Biopharma AB (publ) share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Market capitalisation: €97.1m. The latest transaction was reported on 3 August 2026 (Sale). Among the most active insiders: Henrik Sundin. All data is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Hamlet Biopharma AB (publ) is a Swedish biopharmaceutical company listed on the Stockholm Stock Exchange. It focuses on developing innovative treatments for cancer.